Scroll to Top

USA Stock Report

Real Time Stocks News

Boston, MA, 04/09/2014 (usastockreports) –  Chief Justice John Roberts of U.S. Supreme Court have asked the generic-drug makers to answer to Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) on the company’s bid. The drug makers have still not responded on the matter of patent fight over Copaxone. It is Teva’s top-selling multiple sclerosis drug. The court...

Boston, MA, 04/07/2014 (usastockreports) – Is this the do or die situation for Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), after falling consecutively for the second time to get its ‘808 Patent’ on Copaxone®. The PTO or U.S Patent and Trademark Office declared that the reissue of the ‘808 Patent’ was called off, as the patent was found invalid by...

Boston, MA, 03/12/2014 – Oncogenex Pharmaceuticals Inc (NASDAQ:OGXI) is concerned with the development of new cancer products. Treatment for cancer has global market opportunity and the company has been hoping that its product pipeline will soon come of age to propel its revenue and earnings. However, investors are not pretty sure whether to hit the panic button...